Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy programs have been updated Feb. 1, 2022:
Effective March 1, 2022:
- Soliris/Ultomiris
- Winlevi
- Weight Loss Agents (KS Turnpike Authority groups only)
- Androgens/Anabolic Steroids
- Evenity
- Scenesse
- Strensiq
- Sucraid
- SA Oncology
- Multiple Sclerosis
If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.